100. Food and Drug Administration, H.a.H.S., Biological produ cts; bacterial vaccines and toxoids; implementation of efficacy review. Final rule and final order. 2004: Federal Register. p. 255- 267. 101. Atkinson, W.L., et al., General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP) . 2002: Centers for Disease Control and Prevention. p. 1 -35. 102. Myers, M.G., et al., Pri mary immunization with tetanus and diphtheria toxoids. Reaction rates and immunogenicity in older children and adults. JAMA, 1982. 248(19): p. 2478 -2480. 103. Vitek, C.R. and M. Wharton, Diphtheria Toxoid. 5 ed. Vaccines, ed. S.A. Plotkin, W.A. Orenstein, and P.A. Offit. 2008: Saunders. 104. Baxter, D., Active and passive immunity, vaccine types, excipients and licensing. Occupational Medicine, 2007. 57(8): p. 552 -556. 105. Heimberger, A.B., et al., Bone marrow -derived dendritic cells pulsed with tumor homo genate induce immunity against syngeneic intracerebral glioma. Journal of Neuroimmunology, 2000. 103 (1): p. 16 -25.